SCHEMBL20081720

SCHEMBL20081720

CC(C)S(=O)(=NN)c1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CA12 O43570 1/20 0.44
▸ CA1 P00915 1/20 0.44
▸ CA2 P00918 1/20 0.44
▸ CA3 P07451 1/20 0.44
▸ CA4 P22748 1/20 0.44
▸ CA6 P23280 1/20 0.44
▸ CA5A P35218 1/20 0.44
▸ CA7 P43166 1/20 0.44
▸ PLA2G7 Q13093 1/20 0.44
▸ CA9 Q16790 1/20 0.44
▸ CA13 Q8N1Q1 1/20 0.44
▸ CA14 Q9ULX7 1/20 0.44
▸ CA5B Q9Y2D0 1/20 0.44
▸ KDM4E B2RXH2 2/20 0.43
▸ HTR6 P50406 2/20 0.42
▸ PSIP1 O75475 1/20 0.41
▸ SMN1; SMN2 Q16637 3/20 0.39
▸ ALDH1A1 P00352 3/20 0.39
▸ TSHR P16473 2/20 0.39
▸ HSD17B10 Q99714 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18402598 0.83 KDM4E (0.43) CA12CA1CA2CA3CA4
SCHEMBL20082066 0.81 KDM4E (0.42) CA12CA1CA2CA3CA4
SCHEMBL24394631 0.74 HSD11B1 (0.41) KDM4ESMN1; SMN2ALDH1A1TSHRLMNA
SCHEMBL778854 0.72 HTR6 (0.50) CA12CA1CA2CA3CA4
SCHEMBL18838428 0.70 CA1 (0.50) CA12CA1CA2CA3CA4
SCHEMBL9412354 0.68 HTR6 (0.46) CA12CA1CA2CA3CA4
SCHEMBL5016541 0.68 CA12 (0.48) CA12CA1CA2CA3CA4
SCHEMBL17527530 0.68 HTR6 (0.46) CA12CA1CA2CA3CA4
SCHEMBL20081727 0.68 ALDH1A1 (0.39) CA12CA1CA2CA3CA4
SCHEMBL4327138 0.67 HTR6 (0.50) CA12CA1CA2CA3CA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3395818-B1 2-(MORPHOLIN-4-YL)-1,7-NAPHTHYRIDINES Bayer Pharma AG (DE) 2021-09-22 — — EP disclosed
EP-3177619-B1 2-(MORPHOLIN-4-YL)-1,7-NAPHTHYRIDINES Bayer Pharma AG (DE) 2018-04-25 — — EP disclosed
Send feedback